相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Randomized phase III study of gemcitabine, cisplatin plus S-1 versus gemcitabine, cisplatin for advanced biliary tract cancer (KHBO1401-MITSUBA)
Tatsuya Ioka et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2023)
Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial
Eva Versteijne et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Prognostic relevance of lymph node regression on survival in esophageal cancer: a systematic review and meta-analysis
Eliza Hagens et al.
DISEASES OF THE ESOPHAGUS (2022)
How I treat biliary tract cancer
A. Lamarca et al.
ESMO OPEN (2022)
Outcomes of neoadjuvant therapy for cholangiocarcinoma: A review of existing evidence assessing treatment response and R0 resection rate
Viet H. Le et al.
JOURNAL OF SURGICAL ONCOLOGY (2021)
Neoadjuvant Chemotherapy for Intrahepatic Cholangiocarcinoma: A Propensity Score Survival Analysis Supporting Use in Patients with High-Risk Disease
Ovie Utuama et al.
ANNALS OF SURGICAL ONCOLOGY (2021)
Revision Surgery for Incidental Gallbladder Cancer-Challenging the Dogma: Ideal Timing and Real-World Applicability
Shraddha Patkar et al.
ANNALS OF SURGICAL ONCOLOGY (2021)
Neoadjuvant therapy versus surgery first for ampullary carcinoma: A propensity score-matched analysis of the NCDB
Marissa Guo et al.
JOURNAL OF SURGICAL ONCOLOGY (2021)
Current Status and Future Perspectives of Perioperative Therapy for Resectable Biliary Tract Cancer: A Multidisciplinary Review
Changhoon Yoo et al.
CANCERS (2021)
PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer
Yoon-Koo Kang et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Survival Benefit of Primary Tumor Resection Among Elderly Patients with Pancreatic Neuroendocrine Tumors
Junya Toyoda et al.
WORLD JOURNAL OF SURGERY (2021)
Survival benefit of lymphadenectomy for gallbladder cancer based on the therapeutic index: An analysis of the US extrahepatic biliary malignancy consortium
Kota Sahara et al.
JOURNAL OF SURGICAL ONCOLOGY (2020)
Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone with or without adjuvant chemotherapy in incidentally detected gallbladder carcinoma after simple cholecystectomy or in front of radical resection of BTC (ICC/ECC) - a phase III study of the German registry of incidental gallbladder carcinoma platform (GR)- the AIO/ CALGP/ ACO- GAIN-trial
Thorsten O. Goetze et al.
BMC CANCER (2020)
Neoadjuvant modified FOLFIRINOX followed by postoperative gemcitabine in borderline resectable pancreatic adenocarcinoma: a Phase 2 study for clinical and biomarker analysis
Changhoon Yoo et al.
BRITISH JOURNAL OF CANCER (2020)
Phase II study assessing tolerability, efficacy, and biomarkers for durvalumab (D) ± tremelimumab (T) and gemcitabine/cisplatin (GemCis) in chemo-naïve advanced biliary tract cancer (aBTC).
Do-Youn Oh et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Very Early Recurrence After Liver Resection for Intrahepatic Cholangiocarcinoma Considering Alternative Treatment Approaches
Diamantis I. Tsilimigras et al.
JAMA SURGERY (2020)
The Evolving Role of Radiation Therapy in the Treatment of Biliary Tract Cancer
Eleni Gkika et al.
FRONTIERS IN ONCOLOGY (2020)
The role of neoadjuvant chemotherapy or chemoradiotherapy for advanced gallbladder cancer - A systematic review
Abdul R. Hakeem et al.
EJSO (2019)
Downstaging of lymph node metastasis after neoadjuvant intraperitoneal and systemic chemotherapy in gastric carcinoma with peritoneal metastasis
Y. Hao et al.
EJSO (2019)
Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline
Rachna T. Shroff et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study
John N. Primrose et al.
LANCET ONCOLOGY (2019)
Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers: A Phase 2 Clinical Trial
Rachna T. Shroff et al.
JAMA ONCOLOGY (2019)
Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP05)
Fuyuhiko Motoi et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2019)
Gallbladder cancer: surgical management
Robert W. Krell et al.
CHINESE CLINICAL ONCOLOGY (2019)
Chemoradiotherapy for Initially Unresectable Locally Advanced Cholangiocarcinoma
Tatsuaki Sumiyoshi et al.
WORLD JOURNAL OF SURGERY (2018)
Multicenter Phase II Study of Oxaliplatin, Irinotecan, and S-1 as First-Line Treatment for Patients with Recurrent or Metastatic Biliary Tract Cancer
Changhoon Yoo et al.
CANCER RESEARCH AND TREATMENT (2018)
Influence of marital status on the survival of adults with extrahepatic/intrahepatic cholangiocarcinoma
Zhiqiang Chen et al.
ONCOTARGET (2017)
Recurrence after resection with curative intent for distal cholangiocarcinoma
K. Komaya et al.
BRITISH JOURNAL OF SURGERY (2017)
Comparison of Number Versus Ratio of Positive Lymph Nodes in the Assessment of Lymph Node Status in Extrahepatic Cholangiocarcinoma
Jun Sakata et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Neoadjuvant Chemoradiation Followed by Surgery for Locally Advanced Gallbladder Cancers: A New Paradigm
Reena Engineer et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Assessing the Impact of Common Bile Duct Resection in the Surgical Management of Gallbladder Cancer
Faiz Gani et al.
JOURNAL OF SURGICAL ONCOLOGY (2016)
Neoadjuvant chemoradiation therapy for cholangiocarcinoma to improve R0 resection rate: The first report of phase II study.
Yu Katayose et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
Joel Shapiro et al.
LANCET ONCOLOGY (2015)
Incidence and survival of gallbladder cancer over three decades: A SEER database study.
Adnan Ali et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Surgical Resection after Downsizing Chemotherapy for Initially Unresectable Locally Advanced Biliary Tract Cancer: A Retrospective Single-center Study
Atsushi Kato et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
A Randomized Trial Comparing Postoperative Adjuvant Chemotherapy with Cisplatin and 5-Fluorouracil Versus Preoperative Chemotherapy for Localized Advanced Squamous Cell Carcinoma of the Thoracic Esophagus (JCOG9907)
Nobutoshi Ando et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Preoperative Versus Postoperative Chemoradiotherapy for Locally Advanced Rectal Cancer: Results of the German CAO/ARO/AIO-94 Randomized Phase III Trial After a Median Follow-Up of 11 Years
Rolf Sauer et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Assessment of lymph node status in gallbladder cancer: location, number, or ratio of positive nodes
Yoshio Shirai et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2012)
Prognostic relevance of the lymph node ratio in surgical patients with extrahepatic cholangiocarcinoma
Y. Oshiro et al.
EJSO (2011)
Cytologically Proven Axillary Lymph Node Metastases Are Eradicated in Patients Receiving Preoperative Chemotherapy With Concurrent Trastuzumab for HER2-Positive Breast Cancer
Laura S. Dominici et al.
CANCER (2010)
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer.
Juan Valle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Tumor regression in mesorectal lymphnodes after neoadjuvant chemoradiation for rectal cancer
M. Caricato et al.
EJSO (2007)
分享论文
